Franklin Resources’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Franklin Resources’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-595,723	Closed	-$8.31M	–	1639
2015 Q2	$8.31M	Hold	595,723	–	–	﹤0.01%	1079
2015 Q1	$14.3M	Hold	595,723	–	–	0.01%	966
2014 Q4	$9.81M	Hold	595,723	–	–	﹤0.01%	1051
2014 Q3	$7.58M	Sell	595,723 -138,900	-19%	-$2.09M	﹤0.01%	1093
2014 Q2	$16.6M	Buy	734,623 +77,000	+12%	+$1.4M	0.01%	930
2014 Q1	$18.6M	Buy	+657,623	New	+$24.4M	0.01%	873

Other funds holding DRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

TAM

Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Franklin Resources's DRNA Position: Q3 2015 in Review

Franklin Resources sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q3 2015, closing a stake of 595,723 shares — an estimated $8.31M sold.

Franklin Resources first reported a position in DRNA in Q1 2014 and held it in 6 quarters. The position peaked at $18.6M in Q1 2014. 51 funds tracked by Wall St. Rank hold DRNA as of Q3 2015.

Franklin Resources reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
Franklin Resources sold 595,723 Dicerna Pharmaceuticals, Inc. shares in Q3 2015, an estimated $8.31M.
Franklin Resources first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2014 and held it in 6 quarters.
Franklin Resources's Dicerna Pharmaceuticals, Inc. position peaked at $18.6M in Q1 2014.
51 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q3 2015.

Based on Franklin Resources's 13F filing for Q3 2015, filed 10 Nov 2015.